Date | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | 12/31/2020 | 5/31/2020 | 12/31/2019 |
---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $1,563,000,000.00 | $1,742,000,000.00 | $1,688,000,000.00 | $1,584,000,000.00 | $960,000,000.00 | -- | $1,533,000,000.00 | -- | -- | -- |
Accounts Receivable Net Current | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Prepaid Expenses and Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Total Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Property Plant and Equipement | -- | -- | -- | -- | $13,000,000.00 | -- | $13,000,000.00 | -- | -- | -- |
Intangible Assets Net | $4,207,000,000.00 | $4,005,000,000.00 | $3,851,000,000.00 | $3,677,000,000.00 | $3,652,000,000.00 | -- | $2,234,000,000.00 | -- | -- | -- |
Goodwill | $1,749,000,000.00 | $1,749,000,000.00 | $1,749,000,000.00 | $1,749,000,000.00 | $1,756,000,000.00 | -- | $1,756,000,000.00 | -- | -- | -- |
Other Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Total Assets | $70,202,000,000.00 | $63,623,000,000.00 | $62,587,000,000.00 | $59,414,000,000.00 | $55,075,000,000.00 | -- | $48,730,000,000.00 | -- | -- | -- |
Accounts Payable | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Accrued Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Total Current Liabilities | $67,099,000,000.00 | $61,251,000,000.00 | $60,069,000,000.00 | $56,929,000,000.00 | $53,259,000,000.00 | -- | $44,245,000,000.00 | -- | -- | -- |
Long Term Debt | $1,754,000,000.00 | $1,569,000,000.00 | $1,571,000,000.00 | $1,572,000,000.00 | $1,114,000,000.00 | -- | $977,000,000.00 | -- | -- | -- |
Additional Paid-in Capital | $3,185,000,000.00 | $3,178,000,000.00 | $3,173,000,000.00 | $3,167,000,000.00 | $3,162,000,000.00 | -- | $2,750,000,000.00 | -- | -- | -- |
Accumulated Other Comprehensive Loss | $-1,990,000,000.00 | $-3,040,000,000.00 | $-2,610,000,000.00 | $-2,548,000,000.00 | $-2,803,000,000.00 | -- | $734,000,000.00 | -- | -- | -- |
Accumulated Deficit | $1,926,000,000.00 | $2,252,000,000.00 | $1,971,000,000.00 | $1,866,000,000.00 | $1,457,000,000.00 | -- | $1,001,000,000.00 | -- | -- | -- |
Total Stockholders' Equity | $3,103,000,000.00 | $2,372,000,000.00 | $2,518,000,000.00 | $2,485,000,000.00 | $1,816,000,000.00 | -- | $4,485,000,000.00 | $4,074,000,000.00 | $2,737,000,000.00 | $2,585,000,000.00 |
Controlling Interest in Subsidiaries | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Total Liabilities and Equity | $70,202,000,000.00 | $63,623,000,000.00 | $62,587,000,000.00 | $59,414,000,000.00 | $55,075,000,000.00 | -- | $48,730,000,000.00 | -- | -- | -- |
Date | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | 12/31/2020 | 5/31/2020 | 12/31/2019 |
---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | $4,500,000,000.00 | $2,888,000,000.00 | $1,168,000,000.00 | $869,000,000.00 | $2,340,000,000.00 | -- | $3,962,000,000.00 | $1,233,000,000.00 | $155,000,000.00 | -- |
Cost of Revenues | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Research and Development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Selling, General, and Administrative | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Loss from Operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Loss Before Income Taxes | $-35,000,000.00 | -- | -- | -- | $598,000,000.00 | -- | $1,077,000,000.00 | $86,000,000.00 | $-214,000,000.00 | -- |
Earnings Per Share Basic | $-0.47 | $2.47 | $-0.52 | $-1.56 | $4.18 | -- | $8.24 | $1.30 | $-1.51 | -- |
Weighted Average Shares Basic | 124,000,000 | 124,000,000 | 125,000,000 | 125,000,000 | 115,000,000 | -- | 105,000,000 | 105,000,000 | 213,000,000 | -- |
Earnings Per Share Diluted | $-0.47 | $1.93 | $1.04 | $-1.56 | $4.18 | -- | $8.24 | $1.30 | $-1.51 | -- |
Weighted Average Shares Diluted | 124,000,000 | 125,000,000 | 125,000,000 | 125,000,000 | 115,000,000 | -- | 105,000,000 | 105,000,000 | 213,000,000 | -- |
Common Stock Shares Authorized | 500,000,000 | 500,000,000 | 500,000,000 | 500,000,000 | 500,000,000 | 1,000 | 500,000,000 | -- | -- | -- |
Common Stock Shares Outstanding | 126,332,142 | 125,496,745 | 125,591,479 | 126,379,456 | 126,409,904 | -- | 105,000,000 | -- | -- | -- |
Common Stock Value | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -- | $0.00 | -- | -- | -- |
Payments Of Dividends Common Stock | $101,000,000.00 | $75,000,000.00 | $50,000,000.00 | $25,000,000.00 | -- | -- | -- | -- | -- | -- |
Preferred Stock Shares Authorized | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Shares Outstanding | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Value | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Par Or Stated Value Per Share | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Share Price | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |